Patents Assigned to Salient Pharmaceuticals Incorporated
  • Patent number: 8956664
    Abstract: The present disclosure relates generally to the field of mucositis. More particularly, methods and compositions for treating, ameliorating and/or preventing mucositis are provided by administering a clay to the subject in need.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: February 17, 2015
    Assignee: Salient Pharmaceuticals Incorporated
    Inventor: Richard M. Scruggs
  • Publication number: 20130101643
    Abstract: The present disclosure relates generally to the field of proctitis. More particularly, methods and compositions for treating, ameliorating and/or preventing proctitis are provided.
    Type: Application
    Filed: October 19, 2012
    Publication date: April 25, 2013
    Applicant: Salient Pharmaceuticals Incorporated
    Inventor: Salient Pharmaceuticals Incorporated
  • Publication number: 20130101645
    Abstract: The present disclosure relates generally to the field of mucositis. More particularly, methods and compositions for treating, ameliorating and/or preventing mucositis are provided by administering a clay to the subject in need.
    Type: Application
    Filed: October 22, 2012
    Publication date: April 25, 2013
    Applicant: Salient Pharmaceuticals Incorporated
    Inventor: Salient Pharmaceuticals Incorporated